Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

BACKGROUND: Our aim was to determinate bone mineral density (BMD), levels of biochemical markers and cytokines in children with chronic hepatitis B treated with interferon (IFN)-alpha and to investigate effect of IFN-alpha therapy on these variables. To the best of our knowledge, this is first study...

Descripción completa

Detalles Bibliográficos
Autores principales: Gur, Ali, Dikici, Bünyamin, Nas, Kemal, Bosnak, Mehmet, Haspolat, Kenan, Sarac, Aysegul Jale
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242225/
https://www.ncbi.nlm.nih.gov/pubmed/16171525
http://dx.doi.org/10.1186/1471-230X-5-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242225/
https://www.ncbi.nlm.nih.gov/pubmed/16171525
http://dx.doi.org/10.1186/1471-230X-5-30

Ejemplares similares